| Autor: |
Mammana C; Division of Cardiology, Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy. cmammana@ospedaliriuniti.bergamo.it, Tespili M, Costalunga A, Jacovoni A, Veritti U, Lorini L, Ferrazzi P, Gavazzi A |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2006 Jun; Vol. 7 (6), pp. 443-7. |
| DOI: |
10.2459/01.JCM.0000228698.37773.d2 |
| Abstrakt: |
End-stage heart failure refractory to medical therapy is a clinical challenge. Heart transplantation is considered the best strategy, but it remains burdened with substantial limitations due to the scanty availability of facilities with a transplant programme, donor shortage, and unpredictable waiting lists. Alternatively, assist devices may allow an improvement of the haemodynamic conditions, modifying the history of end-stage heart failure and introducing new management strategies. The goal of a minimally invasive short-term circulatory support device in the treatment of end-stage heart failure patients awaiting heart transplant is to restore the haemodynamic conditions and to improve end-organ dysfunction, with a low incidence of major adverse cardiac events. This report describes the first implantation in Italy of a new percutaneous circulatory support device, the Cancion cardiac recovery system, in a patient with severe end-stage heart failure listed for transplantation. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
